Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: AZD9977
Study Title: A study to learn how different forms and doses of AZD9977 act in the body in healthy participants

Thank you!
Thank you to the participants who took part in the clinical study for the study drug AZD9977. AstraZeneca AB sponsored this study and thinks it is important to share the results. An independent non-profit organization called CISCRP helped prepare this summary of the study results.
If you participated in the study and have questions about the results, please speak with the doctor or staff at your study site.

What is happening with the study now?
The study started in February 2019 and ended in April 2019. There were 2 parts to the study, called Part A and Part B.
The study included 12 participants in the United Kingdom.
The sponsor reviewed the data collected when the study ended and created a report of the results. This is a summary of that report.